By Alexander Bueso
Date: Thursday 11 Jun 2020
(Sharecast News) - Spain's Grifols has begun production of its hyperimmune globulin, the first treatment specifically designed for use against SARS-CoV-2.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 9.45 |
| Change Today | $ 0.26 |
| % Change | 2.83 % |
| 52 Week High | $10.85 |
| 52 Week Low | $6.39 |
| Volume | 257,639 |
| Shares Issued | 261.43m |
| Market Cap | $2,470.47m |
| RiskGrade | 133 |
| Time | Volume / Share Price |
| 14:01 | 100 @ $9.45 |
| 14:01 | 100 @ $9.45 |
| 13:59 | 500 @ $9.45 |
| 13:59 | 100 @ $9.44 |
| 13:59 | 115 @ $9.45 |
You are here: research